PTCT - CIK 0001070081
PTC THERAPEUTICS, INC. (PTCT) reported revenue of $1.73B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $1.73B | +114.5% |
| FY 2024 | $806.78M | -14.0% |
| FY 2023 | $937.82M | +34.2% |
| FY 2022 | $698.80M | +29.7% |
| FY 2021 | $538.59M | +41.4% |
| FY 2020 | $380.77M | +24.0% |
| FY 2019 | $306.98M | +16.0% |
| FY 2018 | $264.73M | +36.2% |
| FY 2017 |
PTC THERAPEUTICS, INC. (PTCT) reported revenue of $1.73B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, PTC THERAPEUTICS, INC.'s revenue grew from $105.41M to $1.73B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $194.39M |
| +135.0% |
| FY 2016 | $82.70M | +124.9% |
| FY 2015 | $36.77M | +45.6% |
| FY 2014 | $25.25M | -27.2% |
| FY 2013 | $34.70M | +2.2% |
| FY 2012 | $33.95M | -67.8% |
| FY 2011 | $105.41M | - |